Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice

Journal of Ethnopharmacology

Volumn 109, Issue 2, 2007, Pages 258-263

  Ferreira, Maria Elena ^a   Nakayama, Hector ^a   de Arias, Antonieta Rojas ^a   Schinini, Alicia ^a   de Bilbao, Ninfa Vera ^a   Serna, Elva ^a   Lagoutte, Delphine ^b   Soriano Agatón, Flor ^b   Poupon, Erwan ^b   Hocquemiller, Reynald ^b   Fournet, Alain ^c  

^a UNIVERSIDAD NACIONAL DE ASUNCIÓN   (Paraguay)

^b UNIVERSITÉ PARIS SUD   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Canthin 6 one; Chagas disease; Experimental treatment; Paraguay; Rutaceae; Zanthoxylum chiloperone

Indexed keywords

5 METHOXYCANTHIN 6 ONE; ALKALOID; ALKALOID DERIVATIVE; ANTIPARASITIC AGENT; BENZNIDAZOLE; CANTHIN 6 ONE ALKALOID; CANTHIN 6 ONE DERIVATIVE; CANTHIN 6 ONE N OXIDE; PLANT EXTRACT; UNCLASSIFIED DRUG; ZANTHOXYLUM CHILOPERONE EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG TOLERANCE; FEMALE; IN VIVO STUDY; LONG TERM CARE; MALE; MOUSE; NONHUMAN; PARASITEMIA; RUTACEAE; SEROLOGY; SURVIVAL; TREATMENT OUTCOME; TRYPANOSOMA CRUZI; ZANTHOXYLUM; ZANTHOXYLUM CHILOPERONE;

ANIMALIA; MUS; RUTACEAE; TRYPANOSOMA CRUZI; ZANTHOXYLUM;

ALKALOIDS; ANIMALS; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; INDOLES; MALE; MICE; MICE, INBRED BALB C; NAPHTHYRIDINES; NITROIMIDAZOLES; SURVIVAL RATE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; ZANTHOXYLUM;

EID: 33845894735     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.07.028     Document Type: Article

References (19)

1. Cano M.I., Gruber A., Vazquez A.M., Cortés A., Levin M.J., González A., Degrave W., Rondinelli E., Zingales B., Ramirez J.L., Alonso C., Requena J.M., and Silveira J.F. Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi genome project. Molecular and Biochemical Parasitology 71 (1995) 273-278
2. Cerecetto H., and Gonzalez M. Chemotherapy of Chagas' disease: status and new developments. Current Topics in Medicinal Chemistry 2 (2002) 1187-1213
3. Ferreira M.E., Rojas de Arias A., Torres de Ortiz S., Inchausti A., Nakayama H., Thouvenel C., Hocquemiller R., and Fournet A. Leishmanicidal activity of canthin-6-one alkalloids isolated from Zanthoxylum chiloperone var. angustifolium. Journal of Ethnopharmacology 80 (2002) 199-202
4. Lira R., Contreras L.M., Rita R.M., and Urbina J.A. Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole. Journal of Antimicrobial Chemotherapy 47 (2001) 537-546
5. Matta Guedes P.M., Urbina J.A., Lana M., Afonso L.C.C., Veloso V.M., Tafuri W.L., Machado-Coelho G.L.L., Chiari E., and Bahia M.T. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts. Antimicrobial Agents and Chemotherapy 48 (2004) 4286-4292
6. Milliken W. Plants for malaria for fever, medicinal species in Latin America (1987), The Royal Botanical Garden, Kew, London
7. Molina J., Brener Z., Romanha A.J., and Urbina J.A. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi. Journal of Antimicrobial Chemotherapy 46 (2000) 137-140
8. Morel C.M. Reaching maturity-25 years of the TDR. Parasitology Today 16 (2000) 522-525
9. OPS/HCP/HCT/140/99. Tratamiento etiológico de la enfermedad de Chagas. Conclusiones de una consulta ténica. Revista de Patologia Tropical 28 (1999) 247-279
10. Schiplander M.T., and Mitscher L.A. A facile one-step synthesis of benz[4,5]canthin-6-one. Journal of Heterocyclic Chemistry 8 (1971) 695-696
11. Spichiger R., and Stutz de Ortega L. Flora del Paraguay: Rutaceae. Ed. Conservatoire et Jardin botaniques de la Ville de Genève. Missouri Botanical Garden (1987) 19-36
12. Thouvenel C., Gantier J.C., Duret P., Fourneau C., Hocquemiller R., Ferreira M.E., Rojas de Arias A., and Fournet A. Antifungal compounds from Zanthoxylum chiloperone var. angustifolium. Phytotherapy Research 17 (2003) 678-680
13. Urbina J.A. Chemotherapy of Chagas disease. Current Pharmaceutical Design 8 (2002) 287-295
14. Urbina J.A., and Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends of Parasitology 11 (2003) 495-501
15. Urbina J.A., Payares G., Sanoja C., Lira R., and Romanha A.J. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. International Journal of Antimicrobial Agents 21 (2003) 27-38
16. Urbina J.A., Payares G., Sanoja C., Molina J., Lira R., Brener Z., and Romanha A.J. Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. International Journal of Antimicrobial Agents 21 (2003) 39-48
17. Vinhaes M.C., and Schofield C.J. Trypanosomiasis control: surmounting diminishing returns. Trends of Parasitology 19 (2003) 112-113
18. World Health Organization. Thirteenth Programme Report, UNDP/World Bank/World Health Organization for Research and Training in Tropical Diseases (1997), World Health Organization, Geneva
19. World Health Organization, 2002. Control of Chagas Disease, Technical Reports. Ser. 2905, pp. 1-109.